Throughout a busy 2023, Pfizer accomplished a lot, from strengthening our efforts to change the trajectory of cancer care, to harnessing the unlimited potential of AI and continuing to strive for health equity around the world. Learn more about that work and hear from our CEO about how our dedication to breakthrough innovation is grounded in our values of courage, excellence, equity, and joy, in our newly released Annual Review.
Â
We've also published our 2023 Impact Report, which highlights our Environmental, Social, and Governance (ESG) work. The Impact Report spotlights ESG and how we’re integrating sustainable practices into our core business every day. Read about the work we're doing to improve the health of the planet and its people. Â
Â
Speaking of people, we're happy to share our fifth consecutive study on pay equity at Pfizer. This study assessed pay equity for gender worldwide and for minorities in the United States based on compensation data, including base pay and bonuses, and measured the difference between similar groups of employees when adjusting for factors such as role, grade, job level, and location. Check on our progress.
Â
Like equity, diversity plays a huge role at Pfizer, and this month we have a look at a key component of that work, our Multicultural Health Equity Collective. Since its launch in 2014, we’ve joined our partners in more than 600 community health engagement and outreach events and programs reaching more than 1.5 million people in the United States. Learn more about how we're striving to create a world without health disparities.
Then catch up with Pfizer on social media via our monthly round-up. This month, CEO Albert Bourla emphasized our plans to outdo cancer, our Chief Global Supply Officer discussed the role diversity plays in our supply chain, and our scientists and social media managers jumped on a fun TikTok trend. Don't miss it!
Â
Thanks for reading!Â